ArticleClinical ophthalmology (Auckland, N.Z.)2026
Investigating Non-Ocular Factors Affecting Postoperative Recovery Following Uveitic Cataract Surgery.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cataract surgery in eyes affected by uveitis presents unique challenges, but the non-ocular factors influencing postoperative recovery are not fully understood. While earlier studies have mainly focused on ocular prognostic factors, variables such as cumulative inflammatory burden, phacoemulsification energy, and systemic immunomodulation have not been thoroughly evaluated. This study aims to identify independent predictors of visual outcomes and steroid-free recovery time after cataract surgery for uveitic cataracts. Methods: This retrospective study included 54 eyes of adults with uveitis-associated cataracts who underwent phacoemulsification with intraocular lens (IOL) implantation at a single center. The primary outcomes were postoperative month-1 best-corrected visual acuity (BCVA) and steroid-free recovery time. Multivariable regression analysis identified independent predictors among preoperative BCVA, uveitis attack count, cumulative dissipated energy (CDE), and immunomodulatory therapy type. All patients on bDMARDs had been receiving therapy for at least 3 months prior to surgery and continued their regimen perioperatively. Results: The mean age of the patients was 38.6 ± 7.9 years. The diagnoses included axial spondyloarthritis (40.7%), Behçet's disease (33.3%), juvenile idiopathic arthritis (11.1%), idiopathic uveitis (11.1%), and sarcoidosis (3.7%). Visual acuity improved from 0.23 ± 0.12 to 0.86 ± 0.12 (p<0.001). The median steroid-free recovery period was 13 days. Independent predictors of postoperative BCVA (R Conclusion: Cumulative inflammatory burden and surgical complexity independently predict postoperative recovery in uveitic cataract surgery. Biologic DMARD therapy was linked to faster steroid-free recovery in this observational cohort, supporting further research into optimizing systemic immunomodulation before surgery. Prospective studies with larger sample sizes are needed to confirm these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.